@scienceofpd.bsky.socialInteresting development - one to watch: Andarta Therapeutics has obtained rights to advance Teva's fatty acid synthase (FASN) inhibitor program to develop innovative treatments for #Parkinsons with support via a grant from the Michael J Fox Foundation
www.andartatx.com/articles/agr...
@scienceofpd.bsky.socialHere is another from Dimitri Krainc: "As we celebrate Michael’s Lasker Award, we honor a humanitarian whose compassion has touched countless lives, & a leader whose vision continues to reshape the future of #Parkinsons research"
www.jci.org/articles/vie...
@scienceofpd.bsky.social"& access policies that the #Parkinsons disease community needs"
"Hollywood can be daunting, but it has nothing on the biomedical research enterprise" :)
@scienceofpd.bsky.socialThe 2026 Lasker~Bloomberg Public Service Award honors Michael J. Fox (Michael J. Fox Foundation for #Parkinsons Research) for empowering patients’ voices & accelerating research to find improved therapies & a cure for PD
laskerfoundation.org/winners/park...
@aging-us.bsky.social🎥 #AgingShort:
Abstract #Video about the #Research paper "Protective effects of three herbal extracts on mitochondrial dysfunction in VPS13C-knockdown SH-SY5Y cells: implications for Parkinson’s disease.”
🔗 https://bit.ly/4r4pAF9
#Aging #PaperSpotlight #Parkinsons #OpenAccess
@justacarehomeg1.bsky.socialHome from work just in time to tune into @cureparkinsons.org.uk webinar on #Parkinsons and #Dementia. Learned a lot about Lewy Body dementia; Parkinsons Disease Dementia (PDD) and Dementia with Lewy Bodies (DLB) - their presentation, diagnosis, treatment & hopes for research in future.
@aging-us.bsky.social🔆 #PaperSpotlight:
The #Research paper "Protective effects of three herbal extracts on mitochondrial dysfunction in VPS13C-knockdown SH-SY5Y cells: implications for Parkinson’s disease" was published in Vol. 18.
@parkinsonseurope.bsky.social🔗 All the details are right here: buff.ly/R81DeFG
We would be hugely grateful if you could show your support for Parkinson's Europe and the work we do by donating whatever you can here: buff.ly/cAJtDl3
@asnrehab.bsky.socialAuthors compared task performance & brain activity in dual task walking in people w/ #Parkinsons disease w/ (FOG+) & w/o freezing of gait. FOG+ preserved gait velocity & sacrificed manual task performance. Theta-band neural dynamics may be key for the mechanism.
@celebcharitycinema.bsky.social#CarolCleveland ⭐️of (of #MontyPython )
signed autobiography #PomPomsUp
donated to #ParkinsonsUK #charity 🤍💙
(12/9/24) *2nd anniversary!/
Video🎥here👉> youtu.be/Fawwu3-LMCA
#Parkinsons #ParkinsonsCharity
#ParkinsonsDisease #BeatParkinsons
#MontyPythonCharity #7thPython
@parkinsons.org.uk
@scienceofpd.bsky.socialReeling from past failures, #Parkinsons pipeline enters ‘era of diversification’ - interesting short read from @biospace
www.biospace.com/drug-develop...
@scienceofpd.bsky.socialBiovie moves to Phase 3 with their anti-inflammatory agent Bezisterim (NE3107) in #Parkinsons
investors.bioviepharma.com/news/news-de...
@scienceofpd.bsky.socialNew research finds MC1R loss-of-function variants may define an "identifiable genetic subgroup with accelerated progression, highlighting their utility for potential prognostic stratification & clinical trial enrichment" in European #Parkinsons patients
jamanetwork.com/journals/jam...
@scienceofpd.bsky.socialInteresting: Using data from the China Kadoorie Biobank (N=>500K), researchers report that among individuals who never smoked, higher exhaled carbon monoxide levels were associated with lower #Parkinsons risk; "A potentially protective role of CO in PD etiology"?
jamanetwork.com/journals/jam...
@molneurodegen.bsky.social#Inflammasomes: central mediators of neuroinflammatory #neurodegeneration in #Alzheimers and #Parkinsons disease
Clémence Tropis, Janna Jernigan Posey, Malú Gámez Tansey, @malutansey.bsky.social Michael T. Heneka
@parkinsonseurope.bsky.socialWe would be hugely grateful if you could show your support by donating whatever you can here: buff.ly/cAJtDl3
This will help us keep raising the voices of people with Parkinson's in Europe and beyond!
@biotechstockdaily.bsky.socialThryv Therapeutics has licensed a new class of SGK1 inhibitor compounds from Spanish researchers, extending its platform toward Parkinson's and Alzheimer's disease.
#Biotech #Biotechnology #Health #Alzheimer #Parkinsons
#Research
Follow Us for More!
Disclaimer: This is NOT a financial advice
@worldpdcongress.bsky.social🔬 “Translating Basic Science Into Therapies for PD” — read Dr. Surmeier’s latest WPC blog post & join him Sept. 8 for the next WPC Research Spotlight.
Register & learn more: https://www.worldpdcoalition.org/WPCResearchSpotlight2026
@scienceofpd.bsky.socialResearch attempting to replicate previous results "found no robust evidence that antipsoriatics, allopurinol, or (hydroxy)chloroquine reduce #Parkinsons risk & did not replicate the inverse associations reported by the FINPARK study"
movementdisorders.onlinelibrary.wiley.com/doi/10.1002/...
@mrcppu.bsky.socialTargeted degradation of α-synuclein as a therapeutic approach to suppress pathological aggregation in #Parkinsons disease www.ppu.mrc.ac.uk/news/targete...